Low Carb Diet Boosts Weight Loss for Liver Transplant Recipients With Obesity LCD also positively impacted patients' metabophenotype Nov 06, 2022
Psilocybin for Depression; What's the Best Direct Oral Anticoagulant? Also in TTHealthWatch: hormone therapy to prevent chronic disease Nov 05, 2022 podcast
Pandemic's Impact on Liver Disease in the Spotlight at Liver Meeting A roundup of news from the AASLD annual meeting Nov 04, 2022
FDA Rejects Hep D Drug; Cash for Colonoscopies; Mortality in MAFLD Without Obesity News and commentary from the world of gastroenterology and hepatology Nov 03, 2022
One in Eight U.S. Adult Deaths Involved Too Much Booze Study details premature deaths after excessive alcohol use pre-pandemic, especially in the young Nov 01, 2022
Continuing Ozanimod Prevented More Relapses in Ulcerative Colitis Disease control also maintained with temporary withdrawal, at least initially Oct 28, 2022
Oral Microbiome Therapy Tied to Low Recurrence of C. Diff ECOSPOR IV study found low recurrence regardless of the number of prior episodes Oct 27, 2022
Upadacitinib Maintenance Triples Clinical Remissions in Crohn's Disease U-ENDURE trial also hit co-primary endpoint for endoscopic response Oct 27, 2022
Entyvio for Kid IBD; Phase III Win in PFIC; Drug Flops for Eosinophilic Esophagitis News and commentary from the world of gastroenterology and hepatology Oct 27, 2022
Two More IBD Drugs Cleared for Safety During Pregnancy Ustekinumab, vedolizumab not linked to greater risk of complications Oct 26, 2022
Momentum Builds for Microbiome as RA Trigger Second study published in a week's time to implicate intestinal bacteria in joint pathology Oct 26, 2022
Guselkumab-Golimumab Combo Shows Promise for Ulcerative Colitis More clinical remissions, endoscopic improvements, early trial finds Oct 26, 2022
New HRS Drug Cuts Need for Renal Replacement Tx After Liver Transplant Follow-up data from CONFIRM trial show terlipressin benefit in key subgroup Oct 25, 2022
Adding Electric Stimulation Bests Pyloroplasty Alone for Gastroparesis Randomized trial showed improved symptoms at 3 months with gastric electrical stimulation Oct 25, 2022
Virtual Reality Improved Functional Dyspepsia Symptoms, Quality of Life Intervention "recalibrates the perception of pain in a very powerful manner," researcher explains Oct 24, 2022
New Standard-of-Care Therapy for Advanced Liver Cancer Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone Oct 24, 2022
Higher Upadacitinib Dose May Be Better for UC Maintenance Post-hoc analysis suggested less severe disease and longer remission over 1 year Oct 24, 2022
FDA Approves New CTLA-4 Inhibitor for Cancer Treatment Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
Extra Hep B Vaccine Dose Exceeds Expectations for People With HIV Seroprotection seen in 100% of participants after three doses of Heplisav-B vaccine Oct 23, 2022
Oral Microbiome Therapy for Recurrent C. Diff Mostly Holds Up at 6 Months Half as many patients receiving SER-109 experienced recurrences versus placebo group Oct 21, 2022
Long-Term Xeljanz for UC; AGA Drops Obesity Drug Guidelines; PPIs & Cystic Fibrosis? News and commentary from the world of gastroenterology and hepatology Oct 20, 2022
Screening Colonoscopy: Where Do We Go From Here? The surprising results of the NordICC trial must be placed into proper context Oct 20, 2022
Does Rheumatoid Arthritis Get Its Start in the Gut? Patients and at-risk individuals show antibodies to common intestinal bacterium Oct 20, 2022
Do Crohn's Patients Do Better With Early Surgery? Danish study finds fewer reoperations, though higher risk for hospitalization Oct 20, 2022
Probiotics in the ICU Linked to Higher Risk of Central Line Infections, Death Powder formulations associated with highest risk of infection Oct 19, 2022
Extra Pounds May Blunt Benefit of Aspirin in Advanced Colorectal Cancer Significant association with survival only seen in patients with a normal BMI before diagnosis Oct 14, 2022
Eating More Unprocessed Foods Tied to Lower Risk of Crohn's Disease No association seen for ulcerative colitis, however Oct 14, 2022
An Intestinal Transplant First; 4-Year Stelara Data in UC; Lymphoma After Anti-TNF News and commentary from the world of gastroenterology and hepatology Oct 13, 2022
U.S. Experts Weigh In on Colonoscopy Status in Wake of European Trial Concerns abound after study suggests colonoscopy may be less effective than expected Oct 12, 2022
Vonoprazan Just as Good or Better Than Lansoprazole for Erosive Esophagitis Randomized trial shows noninferiority for healing and superiority for maintaining healing Oct 12, 2022
One Sigmoidoscopy Yields Long-Term Reduction in CRC Incidence, Death Pooled analysis finds 20% to 21% lower risk for CRC mortality, incidence at 15 years Oct 10, 2022
If You Invite 455 People to Colonoscopy, You'll Stop One Case of Cancer Risk of colorectal cancer reduced with screening in randomized trial, but less than expected Oct 09, 2022
Bariatric Surgery in NAFLD Tied to Lower Heart Disease Risk In a large cohort, surgery associated with 49% lower risk of CVD versus nonsurgical care Oct 07, 2022
Neoadjuvant CRT Tied to Survival Benefit in Older Rectal Cancer Patients This standard of care is still often not used in patients over 80, study authors say Oct 06, 2022
Can Norovirus Trigger Crohn's? Phase III NASH Trial Flops; Social Isolation in IBD News and commentary from the world of gastroenterology and hepatology Oct 06, 2022
POEM Trial Results Hold Firm for Long-Term Efficacy in Achalasia Five-year data support peroral endoscopic myotomy, although reflux esophagitis still a problem Oct 06, 2022
Can a Positive Attitude Keep Appendicitis Patients From Going Under the Knife? Patients who believed antibiotics would be completely successful had lower risk for appendectomy Oct 05, 2022
Some Environmental Pollutants Linked to IBS PM2.5, airborne toxic releases associated with zip code-level IBS incidence in California Oct 04, 2022
TETA4 Noninferior to Penicillamine for Stable Wilson's Disease Phase III study results led to trientine tetrahydrochloride's FDA approval for this rare disorder Oct 03, 2022
FGFR2 Inhibitor Nabs Speedy Approval for Cholangiocarcinoma Futibatinib yielded responses in 42% of patients with FGFR2 gene fusions, rearrangements Oct 03, 2022